These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 4257247

  • 1. Parkinsonism-dementia of Guam: treatment with L-dopa.
    Schnur JA, Chase TN, Brody JA.
    Neurology; 1971 Dec; 21(12):1236-42. PubMed ID: 4257247
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
    van Woert MH, Bowers MB.
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
    [No Abstract] [Full Text] [Related]

  • 4. Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of Guam.
    Brody JA, Chase TN, Gordon EK.
    N Engl J Med; 1970 Apr 23; 282(17):947-50. PubMed ID: 5436031
    [No Abstract] [Full Text] [Related]

  • 5. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
    Johansson B, Roos BE.
    Eur J Clin Pharmacol; 1971 Sep 23; 3(4):232-5. PubMed ID: 5151306
    [No Abstract] [Full Text] [Related]

  • 6. L-Dopa treatment in Parkinson's Disease.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1970 Sep 23; 4(6):348-69. PubMed ID: 4932969
    [No Abstract] [Full Text] [Related]

  • 7. Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.
    Godwin-Austen RB.
    J Neurol Neurosurg Psychiatry; 1971 Jun 23; 34(3):219-23. PubMed ID: 5571307
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J, Sharpe D, Curzon G.
    J Neurol Sci; 1973 May 23; 19(1):1-12. PubMed ID: 4715017
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Parkinson's disease with amantadine and L-Dopa.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1972 May 23; 7(4):228-40. PubMed ID: 4556618
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA, Dowson JH, Ahmed R, Chow R, Gillingham FJ.
    Confin Neurol; 1972 May 23; 34(2):143-8. PubMed ID: 4666057
    [No Abstract] [Full Text] [Related]

  • 15. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973 May 23; 9(6):349-62. PubMed ID: 4712542
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of parkinsonism with L-dopa (study of 105 patients).
    Klawans HL, Garvin JS.
    Dis Nerv Syst; 1969 Nov 23; 30(11):737-46. PubMed ID: 5359046
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA, Dowson JH, Ahmed R, Chow R, Gillingham FJ.
    Confin Neurol; 1972 Nov 23; 34(1):143-8. PubMed ID: 5084388
    [No Abstract] [Full Text] [Related]

  • 18. The effect of L-dopa on monoamine metabolites in Parkinson's disease.
    van Woert MH, Bowers MB.
    Experientia; 1970 Nov 23; 26(2):161-3. PubMed ID: 5308739
    [No Abstract] [Full Text] [Related]

  • 19. Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.
    Chase TN, Watanabe AM.
    Neurology; 1972 Apr 23; 22(4):384-92. PubMed ID: 5062828
    [No Abstract] [Full Text] [Related]

  • 20. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM, Brody JA, Chase TN.
    Neurology; 1974 Mar 23; 24(3):263-5. PubMed ID: 4855953
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.